Home
Fairmount Funds Management reported a 9.99% stake in Spyre Therapeutics SYRE · 9,667,201 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 9.99%
- Last report
- 9.99% · filed 26/04/20
- Shares held
- 9,667,201 sh
- Class
- Common Stock, $0.0001 par value
- Event date
- 26/06/23
- Filed
- 26/06/23
9.99% stake · +0.0pp from the last report
- Stake
- 9.99%
- Last report
- 9.99%
- Since last report
- +0.0pp
Spyre Therapeutics trades, last 26 weeks
What else happened in Spyre Therapeutics around then
Filed or reported within 30 days of the trade day · 05/24~07/23Fairmount Funds Management's other 5% stake reports
- Fairmount Funds Management
5% stakeKorsana Biosciences
5% stakeKorsana Biosciences
KRSA
19.99% stake
9,106,420 sh
19.99% stake
Filed 09/11
- Fairmount Funds Management
5% stakeCrescent Biopharma
5% stakeCrescent Biopharma
CBIO
16.52% stake
6,602,408 sh
16.52% stake
Filed 07/20
- Fairmount Funds Management
5% stakeOruka Therapeutics
5% stakeOruka Therapeutics
ORKA
19.5% stake
14,572,917 sh
19.5% stake
Filed 07/01
- Fairmount Funds Management
5% stakeJade Biosciences
5% stakeJade Biosciences
JBIO
19.99% stake
14,069,494 sh
19.99% stake
Filed 06/09
- Fairmount Funds Management
5% stakeEnliven Therapeutics
5% stakeEnliven Therapeutics
ELVN
3.1% stake
1,855,644 sh
3.1% stake
Filed 05/15
